• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov24
Amphastar Pharmaceuticals to Participate in Piper Sandler Healthcare Conference Analyst Fireside Chat
11:00
Nov11
AVI Reports Q3 2025 Earnings
00:17
Nov7
Amphastar Pharma released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 536.78 M and EPS of USD 1.52
00:00
Amphastar Pharma released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 191.84 M (forecast USD 185.07 M), actual EPS USD 0.37 (forecast USD 0.731)
00:00
Oct30
Amphastar Pharma to Release FY2025 Q3 Earnings on November 6 After-Market EST, Forecast Revenue USD 185.07 M, EPS USD 0.731
00:50
Aug12
Amphastar Pharmaceuticals Signs Exclusive Licensing Agreement with Nanjing Anji
10:01

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 191.84 M, Net Income 17.35 M, EPS 0.37

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 174.41 M, Net Income 31.03 M, EPS 0.64

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 170.53 M, Net Income 25.29 M, EPS 0.51

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
ASTX
46.070
+36.50%
+12.320
ABLV
0.9715
+34.87%
+0.251
View More